CS Cancer Solutions - Structured Oncology Intelligence
30-Day Complimentary Pilot

Experience CS Cancer Solutions

Complimentary 30-Day Trial for Hospitals & Cancer Centers

No risk
No commitment
Full access

Experience the Platform Before Making a Decision

We offer hospitals, cancer centers, oncology practices, and navigation teams a 30-day complimentary pilot to experience the full value of CS Cancer Solutions. This pilot allows your team to evaluate how the platform supports patient education, multilingual access, navigator workload reduction, and clinical communication — all before making a purchasing decision.

What's Included in the 30-Day Pilot?

✔ Full Access to the Entire Platform
  • Cancer education pages
  • Rare cancer guidance
  • Specialist & cancer center directory
  • Clinical trial summaries
  • Nutrition & lifestyle guidance
  • Survivorship content
  • Multilingual AI translation (100+ languages)
✔ Dedicated Onboarding Session (30–45 minutes)
  • Platform features walkthrough
  • Workflows for patient education
  • Multilingual tools demonstration
  • Navigator integration guidance
  • Resource sharing strategies
✔ Navigator-Centered Workflow Recommendations
  • New diagnosis support
  • Pre-appointment education
  • Clinical trial conversations
  • Rare cancer case guidance
  • Multilingual patient support
  • Survivorship program tools
✔ Custom Hospital Setup
  • Content categories customization
  • Quick links for specific cancers
  • Navigator resource bundles
  • Language preferences
  • Workflow integration suggestions
✔ Access for Up to 50 Staff Members
  • Nurse navigators
  • Oncologists
  • Physician assistants & NPs
  • Patient educators
  • Social workers
  • Clinical trial coordinators
  • Survivorship teams
✔ Administrator Dashboard & Reporting
  • Weekly usage summaries
  • Most viewed content
  • Language usage analytics
  • Patient engagement metrics
  • Navigator access patterns
✔ Patient Access for Testing

Your team may choose to:

Share pages with real patients
Embed links in patient portal messages
Use information during consults

Hospitals use pilot weeks as mini "real-world tests" to evaluate clarity.

Why Hospitals Say Yes to the Pilot

✔ No cost
✔ No contract
✔ No IT integration required
✔ No PHI collected
✔ No risk
✔ High-value insights
✔ Proven usefulness in the first week

Hospitals typically know within 7–10 days whether CS Cancer Solutions improves patient communication and reduces navigator workload.

Pilot Workflow (Simple & Fast)

1
STEP 1

Kickoff Call (15–20 minutes)

Define goals → set up access → provide instructions

2
STEP 2

Team Training (Optional)

Navigator-focused orientation

3
STEP 3

Full Access Begins

Your team uses the platform freely for 30 days

4
STEP 4

Mid-Pilot Check-In (Optional)

We answer questions, adjust settings, and support needs

5
STEP 5

Final Review (20–30 minutes)

Review what worked, use-case successes, and hospital decision considerations

6
STEP 6

Next Steps

If your hospital finds value, we discuss licensing. If not, no pressure or obligation.

Who Should Participate in the Pilot?

We recommend including:
Oncology nurse navigators
Patient education teams
Clinical trial coordinators
Social workers
Advanced practice providers
Survivorship program staff
Multilingual access coordinators
Oncologists interested in patient literacy

Hospitals report the most success when nurse navigators lead the pilot.

Pilot Success Indicators

Hospitals typically measure:
Increased patient understanding
Decreased navigator time spent correcting misinformation
Better communication with multilingual families
Higher patient satisfaction in education discussions
Reduced confusion for newly diagnosed patients

These metrics help determine whether CS Cancer Solutions should be adopted long-term.

Start Your Complimentary 30-Day Pilot

We would be honored to support your oncology team.

Huippu Prodigy Platforms

© 2025 Huippu Prodigy Platforms, Inc.

CS Cancer Solutions, Inc. (Operating Company)

Evidence-Governed • Informed by Current Peer-Reviewed Research

Independent, Unbiased Oncology Intelligence